These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12151631)

  • 1. An approach for assessing estrogen receptor-mediated interactions in mixtures of three chemicals: a pilot study.
    Charles GD; Gennings C; Zacharewski TR; Gollapudi BB; Carney EW
    Toxicol Sci; 2002 Aug; 68(2):349-60. PubMed ID: 12151631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of interactions of diverse ternary mixtures in an estrogen receptor-alpha reporter assay.
    Charles GD; Gennings C; Zacharewski TR; Gollapudi BB; Carney EW
    Toxicol Appl Pharmacol; 2002 Apr; 180(1):11-21. PubMed ID: 11922773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the interaction of phytoestrogens and synthetic chemicals: an in vitro/in vivo comparison.
    Charles GD; Gennings C; Tornesi B; Kan HL; Zacharewski TR; Bhaskar Gollapudi B; Carney EW
    Toxicol Appl Pharmacol; 2007 Feb; 218(3):280-8. PubMed ID: 17222880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of the immature rat uterotrophic assay to mixtures of estrogens.
    Tinwell H; Ashby J
    Environ Health Perspect; 2004 Apr; 112(5):575-82. PubMed ID: 15064164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
    Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
    Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive estrogenic activities of a binary mixture of 2',4',6'-trichloro- and 2',3',4',5'-tetrachloro-4-biphenylol.
    Ramamoorthy K; Vyhlidal C; Wang F; Chen I; Safe S; McDonnell DP; Leonard LS; Gaido KW
    Toxicol Appl Pharmacol; 1997 Nov; 147(1):93-100. PubMed ID: 9356311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel flexible approach for evaluating fixed ratio mixtures of full and partial agonists.
    Gennings C; Carter WH; Carney EW; Charles GD; Gollapudi BB; Carchman RA
    Toxicol Sci; 2004 Jul; 80(1):134-50. PubMed ID: 15084752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Demonstration of the Uncertainty in Predicting the Estrogenic Activity of Individual Chemicals and Mixtures From an In Vitro Estrogen Receptor Transcriptional Activation Assay (T47D-KBluc) to the In Vivo Uterotrophic Assay Using Oral Exposure.
    Conley JM; Hannas BR; Furr JR; Wilson VS; Gray LE
    Toxicol Sci; 2016 Oct; 153(2):382-95. PubMed ID: 27473340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of endocrine disruptor screening tests in detecting anti-estrogenic effects downstream of receptor-ligand interactions.
    Takeyoshi M; Yamasaki K; Sawaki M; Nakai M; Noda S; Takatsuki M
    Toxicol Lett; 2002 Jan; 126(2):91-8. PubMed ID: 11751013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid-hormone-disrupting chemicals: evidence for dose-dependent additivity or synergism.
    Crofton KM; Craft ES; Hedge JM; Gennings C; Simmons JE; Carchman RA; Carter WH; DeVito MJ
    Environ Health Perspect; 2005 Nov; 113(11):1549-54. PubMed ID: 16263510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxylated benzo[a]pyrene metabolites are responsible for in vitro estrogen receptor-mediated gene expression induced by benzo[a]pyrene, but do not elicit uterotrophic effects in vivo.
    Fertuck KC; Matthews JB; Zacharewski TR
    Toxicol Sci; 2001 Feb; 59(2):231-40. PubMed ID: 11158716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the androgen-sensitive MDA-kb2 cell line for assessing complex environmental mixtures.
    Blake LS; Martinović D; Gray LE; Wilson VS; Regal RR; Villeneuve DL; Ankley GT
    Environ Toxicol Chem; 2010 Jun; 29(6):1367-76. PubMed ID: 20821581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line.
    Legler J; van den Brink CE; Brouwer A; Murk AJ; van der Saag PT; Vethaak AD; van der Burg B
    Toxicol Sci; 1999 Mar; 48(1):55-66. PubMed ID: 10330684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive effects of levonorgestrel and ethinylestradiol on brain aromatase (cyp19a1b) in zebrafish specific in vitro and in vivo bioassays.
    Hinfray N; Tebby C; Garoche C; Piccini B; Bourgine G; Aït-Aïssa S; Kah O; Pakdel F; Brion F
    Toxicol Appl Pharmacol; 2016 Sep; 307():108-114. PubMed ID: 27491593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the combined effects of multiple estrogenic chemicals on MCF-7 human breast cancer cells and a preliminary molecular exploration of the estrogenic proliferative effects and related gene expression.
    Yuan S; Huang C; Ji X; Ma M; Rao K; Wang Z
    Ecotoxicol Environ Saf; 2018 Sep; 160():1-9. PubMed ID: 29783106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of triclosan on the uterotrophic response to extended doses of ethinyl estradiol in the weanling rat.
    Louis GW; Hallinger DR; Stoker TE
    Reprod Toxicol; 2013 Apr; 36():71-7. PubMed ID: 23261820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the reporter gene assay for ER-alpha antagonists with the immature rat uterotrophic assay of 10 chemicals.
    Yamasaki K; Takeyoshi M; Yakabe Y; Sawaki M; Takatsuki M
    Toxicol Lett; 2003 Apr; 142(1-2):119-31. PubMed ID: 12765246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
    Read LD; Greene GL; Katzenellenbogen BS
    Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for Economic Co-operation and Development.
    Owens JW; Ashby J
    Crit Rev Toxicol; 2002; 32(6):445-520. PubMed ID: 12487363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic (cyp19a1b-GFP) zebrafish embryos as a tool for assessing combined effects of oestrogenic chemicals.
    Petersen K; Fetter E; Kah O; Brion F; Scholz S; Tollefsen KE
    Aquat Toxicol; 2013 Aug; 138-139():88-97. PubMed ID: 23721851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.